Michael Magro

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis

Fourth Universal Definition of Myocardial Infarction (2018)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention

The State of US Health, 1990-2010

Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy

Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories

Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

Relation of body mass index to mortality among patients with percutaneous coronary intervention longer than 5years follow-up: A meta-analysis

European Guidelines for Obesity Management in Adults

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Diabetic Cardiomyopathy

Guidelines for the Primary Prevention of Stroke

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Current perspectives in coronary microvascular dysfunction

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

Fourth Universal Definition of Myocardial Infarction (2018)

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Loneliness and Social Isolation as Risk Factors for Mortality

Fourth universal definition of myocardial infarction (2018)

Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014

Does Two‐Dimensional Image Reconstruction from Three‐Dimensional Full Volume Echocardiography Improve the Assessment of Left Ventricular Morphology and Function?

Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study

Four‐year clinical outcome of sirolimus‐ and paclitaxel‐eluting stents compared to bare‐metal stents for the percutaneous treatment of stable coronary artery disease

The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study

Clinical Validation of a Novel Speckle-Tracking–Based Ejection Fraction Assessment Method

Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI Patients

Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents